NEW YORK (GenomeWeb News) – Cellular Dynamics today said that iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.
Terms of the pact were not disclosed.
Cellular Dynamics was the first firm outside of Japan to receive a license to the induced pluripotent stem cell patent portfolio of Shinya Yamanaka, a member of iPS Academia Japan's scientific advisory board. iPS Academia Japan was established to manage the patents and technology arising from Yamanaka's research at Kyoto University.
Cellular Dyanmics, which was founded in 2004, also holds a license to iPSC technology stemming from work by University of Wisconsin at Madison stem cell researcher James Thomson, the company's founder and chief scientific officer.